Law Offices of Gary Martin Hays & Associates
P.C.
75 Ponce De Leon Ave NE Ste 101
Atlanta,
GA 30308(470) 294-1674
www.garymartinhays.com
New York Law Journal | Analysis
By Martin Flumenbaum and Brad S. Karp | December 24, 2019
In their Second Circuit Review column, Martin Flumenbaum and Brad S. Karp discuss 'U.S.v. Calderon,' where the Second Circuit limited the availability of "windfall" restitution awards and narrowed its interpretation of the "proximate cause" requirement for financial fraud victims under the Mandatory Victims Restitution Act of 1996.
By Nicole Lynn | December 20, 2019
Nicole Lynn, of Houston, is a double threat: By day, she's an associate at Norton Rose Fulbright, where she represents financial institutions and energy companies in securities, breach of contract and products liability issues, while at night and on weekends she is a sports agent, hobnobbing and representing players in the NFL and college.
By Andy Clubok, Gavin Masuda, Gregory Mortenson, Morgan Whitworth, Greg Rodgers and Brittany Ruiz | December 20, 2019
In this article, the authors discuss another important advantage of direct listing: the potential to deter private plaintiffs from bringing claims under Section 11 of the Securities Act of 1933, which imposes strict liability for material misstatements or omissions in registration statements.
By C. Ryan Barber | Mike Scarcella | December 17, 2019
Welcome to Compliance Hot Spots -- scroll down for a roundup of new amicus briefs in the CFPB case at the US Supreme Court. Plus: A Latham team, including Kathryn Ruemmler, will advocate for Microsoft in the epic Amazon cloud-computing case. More headlines, new engagements and more below. Thanks for reading!
By Phillip Bantz | December 17, 2019
"Everything moves here much faster than the regular world," Alex Levine said Tuesday, his second day on the job as TokenSoft's first chief legal officer.
By Jenna Greene | December 17, 2019
Plaintiffs alleged the company now known as Bausch Health had "formed a secret network of so-called specialty pharmacies to artificially inflate the sale of Valeant drugs using a variety of fraudulent practices."
By Jenna Greene | December 17, 2019
"Resolving this action enables Bausch Health to close the door on one of the more meaningful and unpredictable liabilities associated with the legacy Valeant era," said the company's CEO.
New York Law Journal | Analysis
By Peter M. Fass | December 16, 2019
In his Real Estate Securities column, Peter Fass discusses a release issued by the SEC on May 3, which proposes amendments to the financial disclosure requirements for financial statements of businesses acquired or to be acquired and for business dispositions. The release changes are intended to improve the information investors receive regarding acquired or disposed businesses, reduce complexity and costs of preparing the required disclosures, and facilitate timely access to capital.
By Jenna Greene | December 13, 2019
'There's no playbook or conventional wisdom out there for how to defend a case like this. We were really writing on a blank slate.'
By Cheryl Miller | December 12, 2019
Welcome to Higher Law -- two firms are joining forces, and we've got highlights below. Plus, the SEC hits a cannabis stock promoter, and Akin Gump's lobbying on CBD. Scroll down for notable headlines and more. Thanks for reading!
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
